Deutsch
 
Hilfe Datenschutzhinweis Impressum
  DetailsucheBrowse

Datensatz

 
 
DownloadE-Mail
  Personalized translational epilepsy research — Novel approaches and future perspectives: Part II: Experimental and translational approaches

Bauer, S., van Alphen, N., Becker, A., Chiocchetti, A., Deichmann, R., Deller, T., et al. (2017). Personalized translational epilepsy research — Novel approaches and future perspectives: Part II: Experimental and translational approaches. Epilepsy & Behavior, 76, 7-12. doi:10.1016/j.yebeh.2017.06.040.

Item is

Externe Referenzen

einblenden:

Urheber

einblenden:
ausblenden:
 Urheber:
Bauer, Sebastian, Autor
van Alphen, Natascha, Autor
Becker, Albert, Autor
Chiocchetti, Andreas, Autor
Deichmann, Ralf, Autor
Deller, Thomas, Autor
Freiman, Thomas, Autor
Freitag, Christine M., Autor
Gehrig, Johannes, Autor
Hermsen, Anke M., Autor
Jedlicka, Peter, Autor
Kell, Christian, Autor
Klein, Karl Martin, Autor
Knake, Susanne, Autor
Kullmann, Dimitri M., Autor
Liebner, Stefan, Autor
Norwood, Braxton A., Autor
Omigie, Diana1, 2, Autor           
Plate, Karlheinz, Autor
Reif, Andreas, Autor
Reif, Philipp S., AutorReiss, Yvonne, AutorRoeper, Jochen, AutorRonellenfitsch, Michael W., AutorSchorge, Stephanie, AutorSchratt, Gerhard, AutorSchwarzacher, Stephan W., AutorSteinbach, Joachim P., AutorStrzelczyk, Adam, AutorTriesch, Jochen, AutorWagner, Marlies, AutorWalker, Matthew C., Autorvon Wegner, Frederic, AutorRosenow, Felix, Autor mehr..
Affiliations:
1Department of Music, Max Planck Institute for Empirical Aesthetics, Max Planck Society, ou_2421696              
2Center for Personalized Translational Epilepsy Research (CePTER), 60528 Frankfurt, Germany, ou_persistent22              

Inhalt

einblenden:
ausblenden:
Schlagwörter: Treatment targets, Personalized medicine, Precision medicine, Biomarkers, New treatment targets
 Zusammenfassung: Despite the availability of more than 15 new “antiepileptic drugs”, the proportion of patients with pharmacoresistant epilepsy has remained constant at about 20–30%. Furthermore, no disease-modifying treatments shown to prevent the development of epilepsy following an initial precipitating brain injury or to reverse established epilepsy have been identified to date. This is likely in part due to the polyetiologic nature of epilepsy, which in turn requires personalized medicine approaches. Recent advances in imaging, pathology, genetics, and epigenetics have led to new pathophysiological concepts and the identification of monogenic causes of epilepsy. In the context of these advances, the First International Symposium on Personalized Translational Epilepsy Research (1st ISymPTER) was held in Frankfurt on September 8, 2016, to discuss novel approaches and future perspectives for personalized translational research. These included new developments and ideas in a range of experimental and clinical areas such as deep phenotyping, quantitative brain imaging, EEG/MEG-based analysis of network dysfunction, tissue-based translational studies, innate immunity mechanisms, microRNA as treatment targets, functional characterization of genetic variants in human cell models and rodent organotypic slice cultures, personalized treatment approaches for monogenic epilepsies, blood–brain barrier dysfunction, therapeutic focal tissue modification, computational modeling for target and biomarker identification, and cost analysis in (monogenic) disease and its treatment. This report on the meeting proceedings is aimed at stimulating much needed investments of time and resources in personalized translational epilepsy research. This Part II includes the experimental and translational approaches and a discussion of the future perspectives, while the diagnostic methods, EEG network analysis, biomarkers, and personalized treatment approaches were addressed in Part I

Details

einblenden:
ausblenden:
Sprache(n): eng - English
 Datum: 2017-06-022017-06-052017-09-142017-11
 Publikationsstatus: Erschienen
 Seiten: -
 Ort, Verlag, Ausgabe: -
 Inhaltsverzeichnis: -
 Art der Begutachtung: -
 Identifikatoren: DOI: 10.1016/j.yebeh.2017.06.040
 Art des Abschluß: -

Veranstaltung

einblenden:

Entscheidung

einblenden:

Projektinformation

einblenden:

Quelle 1

einblenden:
ausblenden:
Titel: Epilepsy & Behavior
Genre der Quelle: Zeitschrift
 Urheber:
Affiliations:
Ort, Verlag, Ausgabe: New York, NY : Elsevier
Seiten: - Band / Heft: 76 Artikelnummer: - Start- / Endseite: 7 - 12 Identifikator: ISSN: 1525-5050